AGILE THERAPEUTICS INC Annual Selling and Marketing Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Agile Therapeutics Inc quarterly/annual Selling and Marketing Expense history and growth rate from 2018 to 2023.
  • Agile Therapeutics Inc Selling and Marketing Expense for the quarter ending June 30, 2024 was $3.78M, a 17.4% decline year-over-year.
  • Agile Therapeutics Inc Selling and Marketing Expense for the twelve months ending June 30, 2024 was $16M, a 26.1% decline year-over-year.
  • Agile Therapeutics Inc annual Selling and Marketing Expense for 2023 was $17.8M, a 41.5% decline from 2022.
  • Agile Therapeutics Inc annual Selling and Marketing Expense for 2022 was $30.4M, a 30.1% decline from 2021.
  • Agile Therapeutics Inc annual Selling and Marketing Expense for 2021 was $43.4M, a 86.6% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $17.8M -$12.6M -41.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $30.4M -$13.1M -30.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $43.4M +$20.2M +86.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-28
2020 $23.3M +$22.2M +2046% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
2019 $1.09M +$143K +15.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-30
2018 $942K Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.